KHLMVGHM
NVO

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Novo Nordisk NVO Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-74,286
Closed -$7.68M – 74
2023
Q4 		$7.68M Hold
74,286
– – 0.53% 59
2023
Q3 		$6.85M Buy
+74,286
New +$6.54M 0.5% 62

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's NVO Position: Q1 2024 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 74,286 shares — an estimated $7.68M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in NVO in Q3 2023 and held it in 2 quarters. The position peaked at $7.68M in Q4 2023. 1,746 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 74,286 Novo Nordisk shares in Q1 2024, an estimated $7.68M.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Novo Nordisk in Q3 2023 and held it in 2 quarters.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Novo Nordisk position peaked at $7.68M in Q4 2023.
  • 1,746 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q1 2024, filed 1 May 2024.